tetano
Editor, Senior Moderator
NPJ Biofilms Microbiomes
. 2022 Aug 24;8(1):67.
doi: 10.1038/s41522-022-00330-y.
Temporal dynamics of oropharyngeal microbiome among SARS-CoV-2 patients reveals continued dysbiosis even after Viral Clearance
Suman Kalyan Paine[SUP] #[/SUP][SUP] 1 [/SUP], Usha Kiran Rout[SUP] #[/SUP][SUP] 2 3 [/SUP], Chandrika Bhattacharyya[SUP] #[/SUP][SUP] 1 [/SUP], Debaprasad Parai[SUP] 2 [/SUP], Mahabub Alam[SUP] 1 [/SUP], Rasmi Ranjan Nanda[SUP] 2 [/SUP], Devashish Tripathi[SUP] 1 [/SUP], Parveena Choudhury[SUP] 1 [/SUP], Chanakya Nath Kundu[SUP] 3 [/SUP], Sanghamitra Pati[SUP] 2 [/SUP], Debdutta Bhattacharya[SUP] 4 [/SUP], Analabha Basu[SUP] 5 [/SUP]
Affiliations
Abstract
The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) pandemic has posed multiple challenges to global public health. Clinical features and sequela of SARS-CoV-2 infection include long-term and short-term complications often clinically indistinguishable from bacterial sepsis and acute lung infection. Post-hoc studies of previous SARS outbreaks postulate secondary bacterial infections with microbial dysbiosis. Oral microbial dysbiosis, particularly the altered proportion of Firmicutes and Proteobacteria, observed in other respiratory virus infection, like influenza, has shown to be associated with increased morbidity and mortality. Oropharynx and lung share similar kinds of bacterial species. We hypothesized that alteration in the Human Oropharyngeal Microbiome in SARS-CoV-2 patients can be a clinical indicator of bacterial infection related complications. We made a longitudinal comparison of oropharyngeal microbiome of 20 SARS-CoV-2 patients over a period of 30 days; at three time points, with a 15 days interval; contrasting them with a matched group of 10 healthy controls. Present observation indicates that posterior segment of the oropharyngeal microbiome is a key reservoir for bacteria causing pneumonia and chronic lung infection on SARS-CoV-2 infection. Oropharyngeal microbiome is indeed altered and its α-diversity decreases, indicating reduced stability, in all SARS-CoV-2 positive individuals right at Day-1; i.e. within ~24 h of post clinical diagnosis. The dysbiosis persists long-term (30 days) irrespective of viral clearance and/or administration of antibiotics. There is a severe depletion of commensal bacteria phyla like Firmicutes among the patients and that depletion is compensated by higher proportion of bacteria associated with sepsis and severe lung infection from phyla Proteobacteria. We also found elevated proportions of certain genus that have previously been shown to be causal for lung pneumonia in studies of model organisms and human autopsies' including Stenotrophomonas, Acenetobactor, Enterobactor, Klebsiella and Chryseobacterium that were to be elevated among the cases. We also show that responses to the antibiotics (Azithromycin and Doxycycline) are not uniform for all individuals.
. 2022 Aug 24;8(1):67.
doi: 10.1038/s41522-022-00330-y.
Temporal dynamics of oropharyngeal microbiome among SARS-CoV-2 patients reveals continued dysbiosis even after Viral Clearance
Suman Kalyan Paine[SUP] #[/SUP][SUP] 1 [/SUP], Usha Kiran Rout[SUP] #[/SUP][SUP] 2 3 [/SUP], Chandrika Bhattacharyya[SUP] #[/SUP][SUP] 1 [/SUP], Debaprasad Parai[SUP] 2 [/SUP], Mahabub Alam[SUP] 1 [/SUP], Rasmi Ranjan Nanda[SUP] 2 [/SUP], Devashish Tripathi[SUP] 1 [/SUP], Parveena Choudhury[SUP] 1 [/SUP], Chanakya Nath Kundu[SUP] 3 [/SUP], Sanghamitra Pati[SUP] 2 [/SUP], Debdutta Bhattacharya[SUP] 4 [/SUP], Analabha Basu[SUP] 5 [/SUP]
Affiliations
- PMID: 36002454
- DOI: 10.1038/s41522-022-00330-y
Abstract
The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) pandemic has posed multiple challenges to global public health. Clinical features and sequela of SARS-CoV-2 infection include long-term and short-term complications often clinically indistinguishable from bacterial sepsis and acute lung infection. Post-hoc studies of previous SARS outbreaks postulate secondary bacterial infections with microbial dysbiosis. Oral microbial dysbiosis, particularly the altered proportion of Firmicutes and Proteobacteria, observed in other respiratory virus infection, like influenza, has shown to be associated with increased morbidity and mortality. Oropharynx and lung share similar kinds of bacterial species. We hypothesized that alteration in the Human Oropharyngeal Microbiome in SARS-CoV-2 patients can be a clinical indicator of bacterial infection related complications. We made a longitudinal comparison of oropharyngeal microbiome of 20 SARS-CoV-2 patients over a period of 30 days; at three time points, with a 15 days interval; contrasting them with a matched group of 10 healthy controls. Present observation indicates that posterior segment of the oropharyngeal microbiome is a key reservoir for bacteria causing pneumonia and chronic lung infection on SARS-CoV-2 infection. Oropharyngeal microbiome is indeed altered and its α-diversity decreases, indicating reduced stability, in all SARS-CoV-2 positive individuals right at Day-1; i.e. within ~24 h of post clinical diagnosis. The dysbiosis persists long-term (30 days) irrespective of viral clearance and/or administration of antibiotics. There is a severe depletion of commensal bacteria phyla like Firmicutes among the patients and that depletion is compensated by higher proportion of bacteria associated with sepsis and severe lung infection from phyla Proteobacteria. We also found elevated proportions of certain genus that have previously been shown to be causal for lung pneumonia in studies of model organisms and human autopsies' including Stenotrophomonas, Acenetobactor, Enterobactor, Klebsiella and Chryseobacterium that were to be elevated among the cases. We also show that responses to the antibiotics (Azithromycin and Doxycycline) are not uniform for all individuals.